(Q45732208)

15 December 2017

Efficacy of a B virus gD DNA vaccine for induction of humoral and cellular immune responses in Japanese macaques (English)

1 reference

15 December 2017

Makoto Hirano

1

1 reference

15 December 2017

Shin Nakamura

2

1 reference

15 December 2017

Fusako Mitsunaga

3

1 reference

15 December 2017

Maki Okada

4

1 reference

15 December 2017

Keiko Shimizu

5

1 reference

15 December 2017

Masahiro Ueda

6

1 reference

15 December 2017

Alice Bennett

7

1 reference

15 December 2017

Richard Eberle

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

15 December 2017

1 reference

15 December 2017

20

1 reference

15 December 2017

19-20

1 reference

15 December 2017

2523-2532

1 reference

The isolation of Monkey B virus (Herpesvirus simiae) from the trigeminal ganglia of a healthy seropositive rhesus monkey

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

B virus infection in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Herpes simplex virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

DNA immunization against experimental genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Protective immune correlates can segregate by vaccine type in a murine herpes model system.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Nucleotide sequence analysis of genes encoding glycoproteins D and J in simian herpes B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Detection of B virus antibody in monkey sera using glycoprotein D expressed in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

A Plaque Assay for the Simian Rotavirus SA11

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Morphogenesis of human rotavirus type 2 Wa strain in MA 104 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Gene mapping and sequence analysis of the unique short region of the simian herpesvirus SA 8 genome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Herpesvirus papio 2, an SA8-like alpha-herpesvirus of baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Coupled effects of polybrene and calf serum on the efficiency of retroviral transduction and the stability of retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Immunization of non-human primates with DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

Herpes simplex virus turns off the TAP to evade host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

A viral inhibitor of peptide transporters for antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900175-5

7 January 2021

10.1016/S0264-410X(02)00175-5

Identifiers

DOI

1 reference

15 December 2017

1 reference